Current Prevalence of Chronic Hepatitis B and C Virus Infection in the General Population, Blood Donors and Pregnant Women in the EU/EEA: a Systematic Review

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 2017 Sep 12

PMID 28891457

Citations 62

Authors

S H I Hofstraat

A M Falla

E F Duffell

S J M Hahne

A J Amato-Gauci

I K Veldhuijzen

L Tavoschi

Affiliations

Soon will be listed here.

Abstract

This systematic review aimed at estimating chronic hepatitis B (HBV) and C virus (HCV) prevalence in the European Union (EU) and Economic Area (EEA) countries in the general population, blood donors and pregnant women. We searched PubMed©, Embase© and Cochrane Library databases for reports on HBV and HCV prevalence in the general population and pregnant women in EU/EEA countries published between 2005 and 2015. Council of Europe data were used for HBV and HCV blood donor prevalence. HBV general population estimates were available for 13 countries, ranging from 0·1% to 4·4%. HCV general population estimates were available for 13 countries, ranging from 0·1% to 5·9%. Based on general population and blood donor estimates, the overall HBV prevalence in the EU/EEA is estimated to be 0·9% (95% CI 0·7-1·2), corresponding to almost 4·7 million HBsAg-positive cases; and the overall HCV prevalence to be 1·1% (95% CI 0·9-1·4), equalling 5·6 million anti-HCV-positive cases. We found wide variation in HCV and HBV prevalence across EU/EEA countries for which estimates were available, as well as variability between groups often considered a proxy for the general population. Prevalence estimates are essential to inform policymaking and public health practice. Comparing to other regions globally, HBV and HCV prevalence in the EU/EEA is low.

Citing Articles

Unveiling the Silent Crisis Amidst Tackling Hepatitis B in African Prisons - A Public Health Emergency.

Scott G, Aborode A, Adesola R, Hope C, Dipeolu O, Ajibade F Health Sci Rep. 2025; 8(3):e70543.

PMID: 40066240 PMC: 11892014. DOI: 10.1002/hsr2.70543.

Detection of substantial numbers of latent tuberculosis and positive hepatitis B serology results in rheumatology patients preparing to receive intensified immunosuppressive therapy in a low-prevalence country: why screening still matters.

Feuchtenberger M, Kovacs M, Nigg A, Schafer A Clin Rheumatol. 2025; .

PMID: 39998600 DOI: 10.1007/s10067-025-07350-x.

Health and socio-demographic background of Ukrainian minors and their families in Germany - challenges for refugee medicine : A cross-sectional study from the German Network University Medicine (NUM).

Hoffmann A, Kobbe R, Denz R, Maier C, Toepfner N, Timmesfeld N Eur J Pediatr. 2024; 184(1):64.

PMID: 39636479 PMC: 11621194. DOI: 10.1007/s00431-024-05847-2.

Seroprevalence of hepatitis B virus and hepatitis C virus infection among pregnant women attending antenatal care at Guhala Primary Hospital, Northwestern Ethiopia.

Belete D, Fekadie E, Kassaw M, Fenta M, Jegnie A, Mulu T BMC Pregnancy Childbirth. 2024; 24(1):512.

PMID: 39075410 PMC: 11285531. DOI: 10.1186/s12884-024-06714-6.

HBV elimination in Europe: Current status and challenges.

Buti M, Duffell E Clin Liver Dis (Hoboken). 2024; 23(1):e0229.

PMID: 38952695 PMC: 11216675. DOI: 10.1097/CLD.0000000000000229.

References

Kohli A, Shaffer A, Sherman A, Kottilil S . Treatment of hepatitis C: a systematic review. JAMA. 2014; 312(6):631-40. DOI: 10.1001/jama.2014.7085. View

Hahne S, Veldhuijzen I, Wiessing L, Lim T, Salminen M, van de Laar M . Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013; 13:181. PMC: 3716892. DOI: 10.1186/1471-2334-13-181. View

Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson J . Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. J Med Virol. 2010; 82(4):546-55. DOI: 10.1002/jmv.21734. View

Calleja-Panero J, Llop-Herrera E, Ruiz-Moraga M, de-la-Revilla-Negro J, Calvo-Bonacho E, Pons-Renedo F . Prevalence of viral hepatitis (B and C) serological markers in healthy working population. Rev Esp Enferm Dig. 2013; 105(5):249-54. DOI: 10.4321/s1130-01082013000500002. View

Lopez-Izquierdo R, Udaondo M, Zarzosa P, Garcia-Ramon E, Garcinuno S, Angel Bratos M . [Seroprevalence of viral hepatitis in a representative general population of an urban public health area in Castilla y León (Spain)]. Enferm Infecc Microbiol Clin. 2007; 25(5):317-23. DOI: 10.1157/13102267. View

Edmunds W, Medley G, Nokes D, Hall A, Whittle H . The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993; 253(1337):197-201. DOI: 10.1098/rspb.1993.0102. View

Salleras L, Dominguez A, Bruguera M, Plans P, Espunes J, Costa J . Seroepidemiology of hepatitis B virus infection in pregnant women in Catalonia (Spain). J Clin Virol. 2009; 44(4):329-32. DOI: 10.1016/j.jcv.2009.01.002. View

Drositis I, Bertsias A, Lionis C, Kouroumalis E . Epidemiology and molecular analysis of hepatitis A, B and C in a semi-urban and rural area of Crete. Eur J Intern Med. 2013; 24(8):839-45. DOI: 10.1016/j.ejim.2013.08.003. View

Hahne S, de Melker H, Kretzschmar M, Mollema L, van der Klis F, van der Sande M . Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiol Infect. 2011; 140(8):1469-80. DOI: 10.1017/S095026881100224X. View

10.

Gheorghe L, Csiki I, Iacob S, Gheorghe C . The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey. Eur J Gastroenterol Hepatol. 2012; 25(1):56-64. DOI: 10.1097/MEG.0b013e328358b0bb. View

11.

Cornberg M, Razavi H, Alberti A, Bernasconi E, Buti M, Cooper C . A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011; 31 Suppl 2:30-60. DOI: 10.1111/j.1478-3231.2011.02539.x. View

12.

Cozzolongo R, Osella A, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V . Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol. 2009; 104(11):2740-6. DOI: 10.1038/ajg.2009.428. View

13.

Gogos C, Fouka K, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H . Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003; 18(6):551-7. DOI: 10.1023/a:1024698715741. View

14.

Kristiansen M, Eriksen B, Maltau J, Holdo B, Jarl Gutteberg T, Mortensen L . Prevalences of viremic hepatitis C and viremic hepatitis B in pregnant women in Northern Norway. Hepatogastroenterology. 2009; 56(93):1141-5. View

15.

Op de Coul E, Hahne S, van Weert Y, Oomen P, Smit C, van der Ploeg K . Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis. 2011; 11:185. PMC: 3160399. DOI: 10.1186/1471-2334-11-185. View

16.

Del Corno G, Civardi E . Intrafamilial transmission of hepatitis B and C viruses in an Italian local health district. Ann Ig. 2006; 18(4):287-95. View

17.

Tolmane I, Rozentale B, Keiss J, Arsa F, Brigis G, Zvaigzne A . The prevalence of viral hepatitis C in Latvia: a population-based study. Medicina (Kaunas). 2011; 47(10):532-5. View

18.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

19.

. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2013; 60(2):392-420. DOI: 10.1016/j.jhep.2013.11.003. View

20.

Goritsas C, Plerou I, Agaliotis S, Spinthaki R, Mimidis K, Velissaris D . HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology. 2000; 47(33):782-5. View